位置:首页 > 蛋白库 > LFTY2_HUMAN
LFTY2_HUMAN
ID   LFTY2_HUMAN             Reviewed;         366 AA.
AC   O00292; B3KNH4; B4E332; E9PDM4; O75611; Q5TE89; Q8NBQ9;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   21-FEB-2001, sequence version 2.
DT   03-AUG-2022, entry version 200.
DE   RecName: Full=Left-right determination factor 2;
DE   AltName: Full=Endometrial bleeding-associated factor;
DE   AltName: Full=Left-right determination factor A;
DE   AltName: Full=Protein lefty-2;
DE   AltName: Full=Protein lefty-A;
DE   AltName: Full=Transforming growth factor beta-4;
DE            Short=TGF-beta-4;
DE   Flags: Precursor;
GN   Name=LEFTY2; Synonyms=EBAF, LEFTA, LEFTYA, TGFB4; ORFNames=PSEC0024;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=9153275; DOI=10.1172/jci119415;
RA   Kothapalli R., Buyuksal I., Wu S.-Q., Chegini N., Tabibzadeh S.;
RT   "Detection of ebaf, a novel human gene of the transforming growth factor
RT   beta superfamily association of gene expression with endometrial
RT   bleeding.";
RL   J. Clin. Invest. 99:2342-2350(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT LRAM ASN-342.
RC   TISSUE=Placenta;
RX   PubMed=10053005; DOI=10.1086/302289;
RA   Kosaki K., Bassi M.T., Kosaki R., Lewin M., Belmont J., Schauer G.,
RA   Casey B.;
RT   "Characterization and mutation analysis of human LEFTY A and LEFTY B,
RT   homologues of murine genes implicated in left-right axis development.";
RL   Am. J. Hum. Genet. 64:712-721(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Teratocarcinoma;
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-length
RT   human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA
RT   libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Required for left-right (L-R) asymmetry determination of
CC       organ systems in mammals. May play a role in endometrial bleeding.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O00292-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O00292-2; Sequence=VSP_045264;
CC   -!- TISSUE SPECIFICITY: Mesenchymal cells of the endometrial stroma.
CC   -!- DEVELOPMENTAL STAGE: Transiently expressed before and during menstrual
CC       bleeding.
CC   -!- PTM: The processing of the protein may also occur at the second R-X-X-R
CC       site located at AA 132-135. Processing appears to be regulated in a
CC       cell-type specific manner.
CC   -!- DISEASE: Left-right axis malformations (LRAM) [MIM:601877]: The defect
CC       includes left pulmonary isomerism, with cardiac anomalies characterized
CC       by complete atrioventricular canal defect and hypoplastic left
CC       ventricle, and interrupted inferior vena cava.
CC       {ECO:0000269|PubMed:10053005}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the TGF-beta family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB53269.1; Type=Miscellaneous discrepancy; Note=Authors have revised their sequence, but have not submitted the revised DNA sequence.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U81523; AAB53269.1; ALT_SEQ; mRNA.
DR   EMBL; AF081511; AAC32600.1; -; Genomic_DNA.
DR   EMBL; AF081508; AAC32600.1; JOINED; Genomic_DNA.
DR   EMBL; AF081509; AAC32600.1; JOINED; Genomic_DNA.
DR   EMBL; AF081510; AAC32600.1; JOINED; Genomic_DNA.
DR   EMBL; AF081513; AAD48145.1; -; mRNA.
DR   EMBL; AK027520; BAG51336.1; -; mRNA.
DR   EMBL; AK075344; BAC11556.1; -; mRNA.
DR   EMBL; AK304549; BAG65344.1; -; mRNA.
DR   EMBL; AL117348; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC035718; AAH35718.1; -; mRNA.
DR   CCDS; CCDS1549.1; -. [O00292-1]
DR   CCDS; CCDS53479.1; -. [O00292-2]
DR   RefSeq; NP_001165896.1; NM_001172425.2. [O00292-2]
DR   RefSeq; NP_003231.2; NM_003240.4. [O00292-1]
DR   AlphaFoldDB; O00292; -.
DR   BioGRID; 112902; 17.
DR   IntAct; O00292; 3.
DR   STRING; 9606.ENSP00000355785; -.
DR   GlyGen; O00292; 1 site.
DR   iPTMnet; O00292; -.
DR   PhosphoSitePlus; O00292; -.
DR   BioMuta; LEFTY2; -.
DR   EPD; O00292; -.
DR   jPOST; O00292; -.
DR   MassIVE; O00292; -.
DR   PaxDb; O00292; -.
DR   PeptideAtlas; O00292; -.
DR   PRIDE; O00292; -.
DR   ProteomicsDB; 19703; -.
DR   ProteomicsDB; 47824; -. [O00292-1]
DR   Antibodypedia; 20763; 294 antibodies from 35 providers.
DR   DNASU; 7044; -.
DR   Ensembl; ENST00000366820.10; ENSP00000355785.5; ENSG00000143768.13. [O00292-1]
DR   Ensembl; ENST00000420304.6; ENSP00000388009.2; ENSG00000143768.13. [O00292-2]
DR   GeneID; 7044; -.
DR   KEGG; hsa:7044; -.
DR   MANE-Select; ENST00000366820.10; ENSP00000355785.5; NM_003240.5; NP_003231.2.
DR   UCSC; uc001hpt.3; human. [O00292-1]
DR   CTD; 7044; -.
DR   DisGeNET; 7044; -.
DR   GeneCards; LEFTY2; -.
DR   HGNC; HGNC:3122; LEFTY2.
DR   HPA; ENSG00000143768; Tissue enhanced (cervix, endometrium).
DR   MalaCards; LEFTY2; -.
DR   MIM; 601877; gene+phenotype.
DR   neXtProt; NX_O00292; -.
DR   OpenTargets; ENSG00000143768; -.
DR   Orphanet; 157769; Situs ambiguus.
DR   PharmGKB; PA27580; -.
DR   VEuPathDB; HostDB:ENSG00000143768; -.
DR   eggNOG; KOG3900; Eukaryota.
DR   GeneTree; ENSGT00390000010056; -.
DR   HOGENOM; CLU_064098_0_0_1; -.
DR   InParanoid; O00292; -.
DR   OMA; VSVYWVQ; -.
DR   PhylomeDB; O00292; -.
DR   TreeFam; TF106462; -.
DR   PathwayCommons; O00292; -.
DR   Reactome; R-HSA-114608; Platelet degranulation.
DR   Reactome; R-HSA-1181150; Signaling by NODAL.
DR   Reactome; R-HSA-1433617; Regulation of signaling by NODAL.
DR   SignaLink; O00292; -.
DR   SIGNOR; O00292; -.
DR   BioGRID-ORCS; 7044; 11 hits in 1054 CRISPR screens.
DR   ChiTaRS; LEFTY2; human.
DR   GenomeRNAi; 7044; -.
DR   Pharos; O00292; Tbio.
DR   PRO; PR:O00292; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; O00292; protein.
DR   Bgee; ENSG00000143768; Expressed in decidua and 126 other tissues.
DR   ExpressionAtlas; O00292; baseline and differential.
DR   Genevisible; O00292; HS.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0031093; C:platelet alpha granule lumen; TAS:Reactome.
DR   GO; GO:0005125; F:cytokine activity; IBA:GO_Central.
DR   GO; GO:0008083; F:growth factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0005160; F:transforming growth factor beta receptor binding; IEA:InterPro.
DR   GO; GO:0030509; P:BMP signaling pathway; IBA:GO_Central.
DR   GO; GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IBA:GO_Central.
DR   GO; GO:0060395; P:SMAD protein signal transduction; IBA:GO_Central.
DR   Gene3D; 2.10.90.10; -; 1.
DR   InterPro; IPR029034; Cystine-knot_cytokine.
DR   InterPro; IPR003942; LRDF.
DR   InterPro; IPR001839; TGF-b_C.
DR   InterPro; IPR001111; TGF-b_propeptide.
DR   InterPro; IPR015615; TGF-beta-rel.
DR   InterPro; IPR017948; TGFb_CS.
DR   PANTHER; PTHR11848; PTHR11848; 1.
DR   Pfam; PF00019; TGF_beta; 1.
DR   Pfam; PF00688; TGFb_propeptide; 1.
DR   PIRSF; PIRSF037402; TGFb4; 1.
DR   PRINTS; PR01427; TGFBETA4.
DR   SMART; SM00204; TGFB; 1.
DR   SUPFAM; SSF57501; SSF57501; 1.
DR   PROSITE; PS00250; TGF_BETA_1; 1.
DR   PROSITE; PS51362; TGF_BETA_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cytokine; Developmental protein; Disease variant;
KW   Disulfide bond; Glycoprotein; Growth factor; Heterotaxy;
KW   Reference proteome; Secreted; Signal.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000255"
FT   PROPEP          22..76
FT                   /note="Or 135"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000033806"
FT   CHAIN           77..366
FT                   /note="Left-right determination factor 2"
FT                   /id="PRO_0000033807"
FT   CARBOHYD        158
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        251..264
FT                   /evidence="ECO:0000250"
FT   DISULFID        263..316
FT                   /evidence="ECO:0000250"
FT   DISULFID        293..351
FT                   /evidence="ECO:0000250"
FT   DISULFID        297..353
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         94..127
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045264"
FT   VARIANT         92
FT                   /note="S -> L (in dbSNP:rs366439)"
FT                   /id="VAR_021980"
FT   VARIANT         286
FT                   /note="P -> L (in dbSNP:rs2295418)"
FT                   /id="VAR_021981"
FT   VARIANT         342
FT                   /note="S -> N (in LRAM; dbSNP:rs121909126)"
FT                   /evidence="ECO:0000269|PubMed:10053005"
FT                   /id="VAR_010385"
FT   CONFLICT        132
FT                   /note="R -> G (in Ref. 3; BAG65344)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        183
FT                   /note="A -> P (in Ref. 4; BAC11556)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   366 AA;  40920 MW;  63A416CAE30F7A39 CRC64;
     MWPLWLCWAL WVLPLAGPGA ALTEEQLLGS LLRQLQLSEV PVLDRADMEK LVIPAHVRAQ
     YVVLLRRSHG DRSRGKRFSQ SFREVAGRFL ASEASTHLLV FGMEQRLPPN SELVQAVLRL
     FQEPVPKAAL HRHGRLSPRS AQARVTVEWL RVRDDGSNRT SLIDSRLVSV HESGWKAFDV
     TEAVNFWQQL SRPRQPLLLQ VSVQREHLGP LASGAHKLVR FASQGAPAGL GEPQLELHTL
     DLRDYGAQGD CDPEAPMTEG TRCCRQEMYI DLQGMKWAKN WVLEPPGFLA YECVGTCQQP
     PEALAFNWPF LGPRQCIASE TASLPMIVSI KEGGRTRPQV VSLPNMRVQK CSCASDGALV
     PRRLQP
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024